13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0002003159
Total reported value
$1.2M
$1.2M
11 檔
1023.3%
As reported in its official Q4 2025 Form 13F filing, Brummer Multi-Strategy AB's tracked investment portfolio stood at $1.2M with 11 total positions.
In Q4 2025, Brummer Multi-Strategy AB displayed an active expansion posture, initiating 9 new positions and adding to 2 existing holdings, outstripping position reductions.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | NMRK | Newmark Group Inc-class A | Stock-Other | 21.01% | +100.00% | NEW | |
| 2 | CI | THE Cigna Group | Stock-Healthcare | 19.66% | — | — | |
| 3 | ARVN | Arvinas Inc | Stock-Other | 11.93% | -12.58% | EXIT | |
| 4 | ABVX | Abivax Sa-adr | Stock-Other | 11.72% | -10.40% | EXIT | |
| 5 | IQV | Iqvia Holdings Inc | Stock-Healthcare | 11.15% | — | — | |
| 6 | MRVI | Maravai Lifesciences Hldgs-a | Stock-Other | 8.99% | -8.95% | EXIT | |
| 7 | BDX | Becton Dickinson And Co | Stock-Healthcare | 6.07% | — | +1001.28% | |
| 8 | ATAI | AtaiBeckley Inc. | Stock-Other | 5.81% | — | — | |
| 9 | SLNOEUR | Soleno Therapeutics Inc | Stock-Other | 2.45% | — | — | |
| 10 | GRML | Greenland Mines LTD | Stock-Other | 1.06% | -0.51% | EXIT | |
| 11 | FHTX | Foghorn Therapeutics Inc | Stock-Other | 0.15% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | BDX | Becton Dickinson And Co | +4.5% | +1001.28% | Add |
| 2 | NMRK | Newmark Group Inc-class A | -43.4% | +5.79% | Add |
| 3 | CI | THE Cigna Group | — | NEW | New buy |
| 4 | ARVN | Arvinas Inc | — | NEW | New buy |
| 5 | ABVX | Abivax Sa-adr | — | NEW | New buy |
| 6 | IQV | Iqvia Holdings Inc | — | NEW | New buy |
| 7 | MRVI | Maravai Lifesciences Hldgs-a | — | NEW | New buy |
| 8 | PTCT | Ptc Therapeutics Inc | — | EXIT | Sold out |
| 9 | ATAI | AtaiBeckley Inc. | — | NEW | New buy |
| 10 | CIGI | Colliers Intl Gr-subord Vot | — | EXIT | Sold out |
| 11 | SLNOEUR | Soleno Therapeutics Inc | — | NEW | New buy |
| 12 | GRML | Greenland Mines LTD | — | NEW | New buy |
| 13 | FHTX | Foghorn Therapeutics Inc | — | NEW | New buy |
According to official SEC Form 13F filings, Brummer Multi-Strategy AB reported a total U.S. public equity portfolio value of $1.2M across 11 disclosed positions in Q4 2025.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including NMRK, CI, ARVN) accounted for 1023.3% of total reported equity market value during Q4 2025.
Top New Position Initiated
CI
市值: $3.3M
Top Position Liquidated / Trimmed
PTCT
前期市值: $1.2M
During Q4 2025, Brummer Multi-Strategy AB's top holdings by market value included NMRK (21.0%)、CI (19.7%)、ARVN (11.9%). The largest single position, NMRK, represented 21.0% of total portfolio value.
In Q4 2025, Brummer Multi-Strategy AB made 13 total portfolio adjustments, initiating 9 new buys, adding to 2 positions, trimming 0 holdings, and fully liquidating 2 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.